Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine kinase (ADK) is a highly conserved enzyme that regulates intracellular and extracellular adenosine concentrations by catalyzing the phosphorylation of adenosine to adenosine monophosphate (AMP). It plays a crucial role in adenine nucleotide homeostasis and modulating adenosine receptor-mediated signaling. ADK dysregulation is implicated in diseases like hypermethioninemia and epilepsy, and it is explored as a potential therapeutic target for diabetes, cancer, and inflammation.
ADK inhibitors increase local or systemic adenosine concentrations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine Kinase (ADK).